Vogenx Appoints Richard Gorman Chief Commercial Officer
MT newswire2026/10/09 13:0209:02 AM EDT, 10/09/2026 (MT Newswires) -- Vogenx (VOGX) said Friday it has appointed board member Richard Gorman as chief commercial officer, effective Oct. 12. Gorman will resign from the board and its committees upon joining management, with Vogenx searching to identify a new independent director, the company said. Vogenx said Gorman will oversee commercial operations and corporate strategy, including market development for post-bariatric hypoglycemia and gastroparesis, as well as business development, partnering and licensing. Gorman most recently served as president of life science commercialization and strategic consulting at Envision Pharma Group, Vogenx said.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF
Crypto prices
More
